Bentz M, Plesch A, Bullinger L, Stilgenbauer S, Ott G, Müller-Hermelink H K, Baudis M, Barth T F, Möller P, Lichter P, Döhner H
Abt. Innere Medizin III der Universität Ulm, Ulm, Germany.
Genes Chromosomes Cancer. 2000 Mar;27(3):285-94.
Until now, few data on additional chromosomal aberrations in t(11;14)-positive mantle cell lymphomas (MCLs) have been published. We analyzed 39 t(11;14)-positive MCLs by either comparative genomic hybridization (CGH; n = 8), fluorescence in situ hybridization (FISH) with a set of DNA probes detecting the most frequent aberrations in B-cell neoplasms (n = 12), or both techniques (n = 19). The t(11;14) was present in all cases. In 37 of 39 cases, chromosomal imbalances were found. In 27 cases, complex karyotypes, i.e., >/= 3 aberrations, were identified. The most frequent aberrations were losses of 13q14-21 or 13q32-34 (27 cases), 9p21 (16 cases), and 11q22-23 (12 cases) and gains of 3q26-29 (19 cases), 8q22-24 (11 cases), and 18q21-22 (9 cases). In 26% of cases (7 of 27) analyzed by CGH, a total of 10 high-level DNA amplifications were identified. Although in comparison with B-cell chronic lymphopcytic leukemia (B-CLL) MCL is characterized by a much higher complexity of chromosomal aberrations, there are striking similarities: 13q14 deletions were identified in more than 50% of both MCL and B-CLL cases. In contrast, in our CGH database containing 293 B-cell lymphomas, this aberration was found in only 11% of other nodal lymphomas. Even more strikingly, 11q deletions, which are present in 20%-30 % of MCL and B-CLL, were found very rarely in other nodal B-cell lymphomas (CGH: 1 of 208 cases; FISH: 1 of 69 cases). These data show that MCL is characterized by specific secondary aberrations and that there may be similarities in the pathogenesis of MCL and B-CLL. Genes Chromosomes Cancer 27:285-294, 2000.
迄今为止,关于t(11;14)阳性套细胞淋巴瘤(MCL)中其他染色体畸变的数据鲜有报道。我们采用比较基因组杂交(CGH;n = 8)、用一组检测B细胞肿瘤中最常见畸变的DNA探针进行荧光原位杂交(FISH;n = 12)或两种技术联合使用(n = 19)的方法,对39例t(11;14)阳性MCL进行了分析。所有病例均存在t(11;14)。在39例中的37例中发现了染色体失衡。在27例中鉴定出复杂核型,即≥3种畸变。最常见的畸变是13q14 - 21或13q32 - 34缺失(27例)、9p21缺失(16例)和11q22 - 23缺失(12例),以及3q26 - 29增益(19例)、8q22 - 24增益(11例)和18q21 - 22增益(9例)。在通过CGH分析的26%的病例(27例中的7例)中,共鉴定出10个高水平DNA扩增。尽管与B细胞慢性淋巴细胞白血病(B - CLL)相比,MCL的特征是染色体畸变的复杂性要高得多,但仍有显著相似之处:在超过50%的MCL和B - CLL病例中都发现了13q14缺失。相比之下,在我们包含293例B细胞淋巴瘤的CGH数据库中,在仅11%的其他淋巴结淋巴瘤中发现了这种畸变。更引人注目的是,11q缺失在20% - 30%的MCL和B - CLL中存在,但在其他淋巴结B细胞淋巴瘤中很少见(CGH:208例中的1例;FISH:69例中的1例)。这些数据表明,MCL具有特定的继发性畸变特征,并且MCL和B - CLL的发病机制可能存在相似性。《基因、染色体与癌症》27:285 - 294,2000年。